ACE2 and Mental deterioration: In the present study, we have shown for the first time that DIZE-mediated enhancement of brain ACE2 activity prevented cognitive decline when administered chronically to young (9–10 months) asymptomatic Tg25676 mice and restored cognitive performance in aged impaired (13–15 months old) Tg2576 mice.